A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorSAVA Healthcare Limited

About this trial

This exploratory, prospective, open-label, single-centre, safety, efficacy and in-use tolerability study of the Utixira Lotion + Utixira Lotion as regimen in healthy adult human subjects with dry or sensitive skin and prone to mild to moderate pruritus or urticaria

Eligibility criteria

Qualifiers

Age: 18 to 55 years (both inclusive) at the time of consent.

Sex: Healthy male and non-pregnant/non-lactating females.

Females of childbearing potential must have a self-reported negative pregnancy test.

Subject are generally in good health.

Disqualifiers

History of any dermatological condition of the skin diseases.

Subject with present condition of allergic response to any cosmetic product.

Subject having allergic response to the ink.

Presence of any broken, chapped, cut, irritated, or scraped skin at the application site.

Trial design

Treatments tested in this trial

  • Utixira Lotion tablet as regimen

Treatment groups

32 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators